Cargando…

Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases

Detalles Bibliográficos
Autores principales:	Shetty, Trupti, Corson, Timothy W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373750/ https://www.ncbi.nlm.nih.gov/pubmed/32760270 http://dx.doi.org/10.3389/fphar.2020.01015

Ejemplares similares

Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction
por: Shetty, Trupti, et al.
Publicado: (2020)

Heme as a Target for Therapeutic Interventions
por: Immenschuh, Stephan, et al.
Publicado: (2017)

Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer
por: Shetty, Trupti, et al.
Publicado: (2021)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
por: Park, Bomina, et al.
Publicado: (2019)

Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
por: He, Ting, et al.
Publicado: (2023)

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
por: Pan, Yunfeng, et al.
Publicado: (2022)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
por: Zhu, Yumeng, et al.
Publicado: (2022)

The ubiquitous mitochondrial protein unfoldase CLPX regulates erythroid heme synthesis by control of iron utilization and heme synthesis enzyme activation and turnover
por: Rondelli, Catherine M., et al.
Publicado: (2021)

Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020)

Heme Cytotoxicity and the Pathogenesis of Immune-Mediated Inflammatory Diseases
por: Larsen, Rasmus, et al.
Publicado: (2012)

Heme on innate immunity and inflammation
por: Dutra, Fabianno F., et al.
Publicado: (2014)

Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
por: Xu, Jingqi, et al.
Publicado: (2021)

Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension
por: Liao, Xiaolin, et al.
Publicado: (2023)

Editorial: Vascular smooth muscle cell fate and vascular remodeling: Mechanisms, therapeutic targets, and drugs, volume I
por: Wang, Qilong, et al.
Publicado: (2022)

Regulation of Heme Synthesis by Mitochondrial Homeostasis Proteins
por: Yien, Yvette Y., et al.
Publicado: (2022)

Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis
por: Araujo, Jesus A., et al.
Publicado: (2012)

Heme Catabolic Pathway in Inflammation and Immune Disorders
por: Wu, Bing, et al.
Publicado: (2019)

Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease
por: Suur, Bianca E., et al.
Publicado: (2022)

Heme Oxygenase, Inflammation, and Fibrosis: The Good, the Bad, and the Ugly?
por: Lundvig, Ditte M. S., et al.
Publicado: (2012)

Heme and HO-1 Inhibition of HCV, HBV, and HIV
por: Schmidt, Warren N., et al.
Publicado: (2012)

Heme oxygenase and the immune system in normal and pathological pregnancies
por: Ozen, Maide, et al.
Publicado: (2015)

Editorial: Heme Oxygenases: Novel Regulators of Reproductive Processes
por: Wong, Ronald J., et al.
Publicado: (2015)

Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria
por: Kuo, Hung-Chou, et al.
Publicado: (2021)

Mitochondrial dysfunction in heart diseases: Potential therapeutic effects of Panax ginseng
por: Cao, Xinxin, et al.
Publicado: (2023)

Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice
por: Kour, Dilpreet, et al.
Publicado: (2023)

Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease
por: Li, Qing, et al.
Publicado: (2021)

From Synthesis to Utilization: The Ins and Outs of Mitochondrial Heme
por: Swenson, Samantha A., et al.
Publicado: (2020)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases
por: Li, Yi-Xuan, et al.
Publicado: (2022)

Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases
por: Luan, Yi, et al.
Publicado: (2021)

Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases
por: Li, Hui, et al.
Publicado: (2021)

Mitochondrial Targeting in Neurodegeneration: A Heme Perspective
por: Fiorito, Veronica, et al.
Publicado: (2018)

Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications
por: Li, Zhi, et al.
Publicado: (2020)

Therapeutic Targeting of Endosome and Mitochondrial Reactive Oxygen Species Protects Mice From Influenza Virus Morbidity
por: To, Eunice E., et al.
Publicado: (2022)

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
por: Ai, Xiaopeng, et al.
Publicado: (2021)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
por: Uddin, Md. Jamal, et al.
Publicado: (2022)

Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
por: Yu, Chao, et al.
Publicado: (2019)

Selecting the right therapeutic target for kidney disease
por: Buvall, Lisa, et al.
Publicado: (2022)

Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nnord00u8lo212emc3fmpe0ot1